After Perry et al. [4] demonstrated the benefit from a combination treatment with radiotherapy and temozolomide followed by 12 cycles of maintenance temozolomide in glioblastoma patients aged ≥65 years, especially those with methylated MGMT, this treatment became the standard therapy for EGP. This evidence concerns the gene MGMT and glioblastoma.